Advertisement
Screener

WHITEHAWK THERAPEUTICS, INC. (WHWK) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

WHITEHAWK THERAPEUTICS, INC. Stock-Based Compensation

WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Stock-Based Compensation of $1.52 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-06

  • WHITEHAWK THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.52M, a 50.76% decline year-over-year.
  • WHITEHAWK THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.19M, a 30.54% increase year-over-year.
  • WHITEHAWK THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.39M, a 28.80% increase year-over-year.
  • WHITEHAWK THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.72M, a 6.30% increase year-over-year.
  • WHITEHAWK THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $9.87M, a 8.91% decline from fiscal 2024.
  • WHITEHAWK THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $10.84M, a 9.33% decline from fiscal 2023.
  • WHITEHAWK THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $11.95M, a 23.97% increase from fiscal 2022.
  • WHITEHAWK THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $9.64M, a 357.88% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 6 month as first filedShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 9 month as first filedShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filed
2026-06-30$1.52M
10-Q · filed 2026-08-06
$3.71M
10-Q · filed 2026-08-06
$6.10M
derived: sum of 3 quarters · filed 2026-08-06
$8.82M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$2.19M
10-Q · filed 2026-05-07
$4.58M
derived: sum of 2 quarters · filed 2026-05-07
$7.30M
derived: sum of 3 quarters · filed 2026-05-07
$10.39M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$2.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$5.11M
derived: sum of 2 quarters · filed 2026-03-12
$8.19M
derived: sum of 3 quarters · filed 2026-08-06
$9.87M
10-K · filed 2026-03-12
2025-09-30$2.72M
10-Q · filed 2025-11-06
$5.80M
derived: sum of 2 quarters · filed 2026-08-06
$7.49M
10-Q · filed 2025-11-06
$9.34M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$3.09M
10-Q · filed 2026-08-06
$4.77M
10-Q · filed 2026-08-06
$6.62M
derived: sum of 3 quarters · filed 2026-08-06
$9.18M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$1.68M
10-Q · filed 2026-05-07
$3.53M
derived: sum of 2 quarters · filed 2026-05-07
$6.09M
derived: sum of 3 quarters · filed 2026-05-07
$8.93M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$1.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$4.41M
derived: sum of 2 quarters · filed 2026-03-12
$7.25M
derived: sum of 3 quarters · filed 2026-03-12
$10.84M
10-K · filed 2026-03-12
2024-09-30$2.56M
10-Q · filed 2025-11-06
$5.40M
derived: sum of 2 quarters · filed 2025-11-06
$8.98M
10-Q · filed 2025-11-06
$12.10M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$2.84M
10-Q · filed 2025-08-07
$6.43M
10-Q · filed 2025-08-07
$9.54M
derived: sum of 3 quarters · filed 2025-08-07
$12.59M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$3.59M
10-Q · filed 2025-05-08
$6.70M
derived: sum of 2 quarters · filed 2025-05-08
$9.75M
derived: sum of 3 quarters · filed 2025-05-08
$12.80M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$3.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28
$6.16M
derived: sum of 2 quarters · filed 2025-03-28
$9.21M
derived: sum of 3 quarters · filed 2025-03-28
$11.95M
10-K · filed 2025-03-28
2023-09-30$3.05M
10-Q · filed 2024-11-06
$6.10M
derived: sum of 2 quarters · filed 2024-11-06
$8.84M
10-Q · filed 2024-11-06
$11.71M
derived: sum of 4 quarters · filed 2024-11-06
2023-06-30$3.05M
10-Q · filed 2024-08-07
$5.79M
10-Q · filed 2024-08-07
$8.66M
derived: sum of 3 quarters · filed 2024-08-07
$11.42M
derived: sum of 4 quarters · filed 2024-08-07
2023-03-31$2.74M
10-Q · filed 2024-05-08
$5.61M
derived: sum of 2 quarters · filed 2024-05-08
$8.37M
derived: sum of 3 quarters · filed 2024-05-08
$10.60M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31$2.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13
$5.63M
derived: sum of 2 quarters · filed 2024-03-13
$7.86M
derived: sum of 3 quarters · filed 2024-03-13
$9.64M
10-K · filed 2024-03-13
2022-09-30$2.76M
10-Q · filed 2023-11-08
$4.99M
derived: sum of 2 quarters · filed 2023-11-08
$6.77M
10-Q · filed 2023-11-08
$8.16M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$2.23M
10-Q · filed 2023-08-09
$4.02M
10-Q · filed 2023-08-09
$5.40M
derived: sum of 3 quarters · filed 2023-08-09
$6.05M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$1.78M
10-Q · filed 2023-05-10
$3.16M
derived: sum of 2 quarters · filed 2023-05-10
$3.81M
derived: sum of 3 quarters · filed 2023-05-10
$3.85M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$1.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29
$2.03M
derived: sum of 2 quarters · filed 2023-03-29
$2.07M
derived: sum of 3 quarters · filed 2023-03-29
$2.11M
10-K · filed 2023-03-29
2021-09-30$648.00K
10-Q · filed 2022-11-09
$687.00K
derived: sum of 2 quarters · filed 2022-11-09
$723.00K
10-Q · filed 2022-11-09
$762.00K
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$39.00K
10-Q · filed 2022-08-10
$557.22K
10-Q · filed 2021-08-11
$75.00K
10-Q · filed 2022-08-10
$902.98K
10-Q · filed 2021-08-11
$114.00K
derived: sum of 3 quarters · filed 2022-08-10
$148.00K
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31$36.00K
10-Q · filed 2022-05-12
$345.76K
10-Q · filed 2021-05-17
$75.00K
derived: sum of 2 quarters · filed 2022-05-12
$109.00K
derived: sum of 3 quarters · filed 2022-05-12
$417.34K
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$39.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17
$73.00K
derived: sum of 2 quarters · filed 2022-03-17
$381.34K
derived: sum of 3 quarters · filed 2022-03-17
$139.00K
10-K · filed 2022-03-17
$1.28M
10-K · filed 2021-03-11
2020-09-30$34.00K
10-Q · filed 2021-11-10
$332.14K
10-Q · filed 2020-11-10
$342.34K
derived: sum of 2 quarters · filed 2021-11-10
$100.00K
10-Q · filed 2021-11-10
$967.95K
10-Q · filed 2020-11-10
-$116.59K
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$308.34K
10-Q · filed 2021-08-11
$635.81K
10-Q · filed 2021-08-11
-$150.59K
derived: sum of 3 quarters · filed 2021-08-11
$495.30K
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$327.47K
10-Q · filed 2021-05-17
-$458.94K
derived: sum of 2 quarters · filed 2021-05-17
$186.96K
derived: sum of 3 quarters · filed 2021-05-17
$791.62K
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$786.40K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
-$140.50K
derived: sum of 2 quarters · filed 2021-03-11
$464.16K
derived: sum of 3 quarters · filed 2021-03-11
$1.09M
10-K · filed 2021-03-11
2019-09-30$645.90K
10-Q · filed 2020-11-10
$1.25M
derived: sum of 2 quarters · filed 2020-11-10
$1.87M
10-Q · filed 2020-11-10
$2.54M
derived: sum of 4 quarters · filed 2020-11-10
2019-06-30$604.66K
10-Q · filed 2020-08-12
$1.23M
10-Q · filed 2020-08-12
$1.89M
derived: sum of 3 quarters · filed 2020-08-12
$2.70M
derived: sum of 4 quarters · filed 2020-08-12
2019-03-31$621.68K
10-Q · filed 2020-05-07
$1.29M
derived: sum of 2 quarters · filed 2020-05-07
$2.10M
derived: sum of 3 quarters · filed 2020-05-07
$2.97M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31$667.97K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$1.47M
derived: sum of 2 quarters · filed 2020-03-16
$2.35M
derived: sum of 3 quarters · filed 2020-03-16
$3.43M
10-K · filed 2020-03-16
2018-09-30$806.41K
10-Q · filed 2019-11-07
$1.68M
derived: sum of 2 quarters · filed 2019-11-07
$2.76M
10-Q · filed 2019-11-07
$3.02M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$877.76K
10-Q · filed 2019-08-08
$877.56K
10-Q · filed 2018-08-14
$1.96M
10-Q · filed 2019-08-08
$2.21M
derived: sum of 3 quarters · filed 2019-08-08
$2.34M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$1.08M
10-Q · filed 2019-05-09
$1.33M
derived: sum of 2 quarters · filed 2019-05-09
$1.46M
derived: sum of 3 quarters · filed 2019-05-09
$1.57M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31$255.14K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
$382.50K
derived: sum of 2 quarters · filed 2019-03-07
$494.02K
derived: sum of 3 quarters · filed 2019-03-07
$649.41K
10-K · filed 2019-03-07
2017-09-30$127.36K
10-Q · filed 2018-11-07
$238.88K
derived: sum of 2 quarters · filed 2018-11-07
$394.27K
10-Q · filed 2018-11-07
$524.33K
derived: sum of 4 quarters · filed 2018-11-07
2017-06-30$111.52K
10-Q · filed 2018-08-14
$266.91K
10-Q · filed 2018-08-14
$396.97K
derived: sum of 3 quarters · filed 2018-08-14
$510.47K
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$155.38K
10-Q · filed 2018-05-15
$285.45K
derived: sum of 2 quarters · filed 2018-05-15
$398.95K
derived: sum of 3 quarters · filed 2018-05-15
$518.50K
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31$130.06K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$243.56K
derived: sum of 2 quarters · filed 2018-03-15
$363.11K
derived: sum of 3 quarters · filed 2018-03-15
$488.33K
10-K · filed 2018-03-15
2016-09-30$113.50K
10-Q · filed 2017-11-13
$233.05K
derived: sum of 2 quarters · filed 2017-11-13
$358.26K
10-Q · filed 2017-11-13
2016-06-30$119.55K
10-Q · filed 2017-08-10
$244.76K
10-Q · filed 2017-08-10
2016-03-31$125.22K
10-Q · filed 2017-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
Foghorn Therapeutics Inc. (FHTX)United States$0.213B-4.43
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Nkarta, Inc. (NKTX)United States$0.205B-1.73
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
MACROGENICS INC (MGNX)United States$0.242B-20.11